Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Floquet, Célia ^a,b   Rousset, Jean Pierre ^a,b   Bidou, Laure ^a,c  

^a INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; APC PROTEIN; BETA CATENIN; GENTAMICIN; NEGAMYCIN; T CELL FACTOR PROTEIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; COMPLEMENTARY DNA;

ARTICLE; CANCER CELL; CELL STRAIN 3T3; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; NONSENSE MUTATION; PREMATURE TERMINATION CODON; STOP CODON; TUMOR SUPPRESSOR GENE; COLORECTAL TUMOR; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOMATOUS POLYPOSIS COLI PROTEIN; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CODON, NONSENSE; COLORECTAL NEOPLASMS; DNA, COMPLEMENTARY; GENES, APC; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 80052333494     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024125     Document Type: Article

References (33)

1. Aoki K, Taketo MM, (2007) Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 120: 3327-3335.
2. Kolligs FT, Bommer G, Goke B, (2002) Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66: 131-144.
3. Groden J, Joslyn G, Samowitz W, Jones D, Bhattacharyya N, et al. (1995) Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 55: 1531-1539.
4. Morin PJ, Vogelstein B, Kinzler KW, (1996) Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A 93: 7950-7954.
5. Laurent-Puig P, Beroud C, Soussi T, (1998) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 26: 269-270.
6. Zingman LV, Park S, Olson TM, Alekseev AE, Terzic A, (2007) Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy. Clin Pharmacol Ther 81: 99-103.
7. Linde L, Kerem B, (2008) Introducing sense into nonsense in treatments of human genetic diseases. Trends Genet 24: 552-563.
8. Rowe SM, Clancy JP, (2009) Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development. BioDrugs 23: 165-174.
9. Arakawa M, Shiozuka M, Nakayama Y, Hara T, Hamada M, et al. (2003) Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice. J Biochem 134: 751-758.
10. Allamand V, Bidou L, Arakawa M, Floquet C, Shiozuka M, et al. (2008) Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes. J Gene Med 10: 217-224.
11. Floquet C, Deforges J, Rousset JP, Bidou L, (2010) Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides. Nucleic Acids Res.
12. Zilberberg A, Lahav L, Rosin-Arbesfeld R, (2010) Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons. Gut 59: 496-507.
13. Bidou L, Hatin I, Perez N, Allamand V, Panthier JJ, et al. (2004) Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment. Gene Ther 11: 619-627.
14. Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, et al. (2000) Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48: 164-169.
15. Aurino S, Nigro V, (2006) Readthrough strategies for stop codons in Duchenne muscular dystrophy. Acta Myol 25: 5-12.
16. Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, et al. (2007) In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study. BMC Med 5: 5.
17. Martin R, Phillips-Jones MK, Watson FJ, Hill LS, (1993) Codon context effects on nonsense suppression in human cells. Biochem Soc Trans 21: 846-851.
18. Manuvakhova M, Keeling K, Bedwell DM, (2000) Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA 6: 1044-1055.
19. Cassan M, Rousset JP, (2001) UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals. BMC Mol Biol 2: 3.
20. Howard MT, Anderson CB, Fass U, Khatri S, Gesteland RF, et al. (2004) Readthrough of dystrophin stop codon mutations induced by aminoglycosides. Ann Neurol 55: 422-426.
21. Burke JF, Mogg AE, (1985) Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res 13: 6265-6272.
22. Yang C, Feng J, Song W, Wang J, Tsai B, et al. (2007) A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin. Proc Natl Acad Sci U S A 104: 15394-15399.
23. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790.
24. Fearon K, McClendon V, Bonetti B, Bedwell DM, (1994) Premature translation termination mutations are efficiently suppressed in a highly conserved region of yeast Ste6p, a member of the ATP-binding cassette (ABC) transporter family. J Biol Chem 269: 17802-17808.
25. Feng YX, Copeland TD, Oroszlan S, Rein A, Levin JG, (1990) Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus. Proc Natl Acad Sci U S A 87: 8860-8863.
26. Salas-Marco J, Bedwell DM, (2005) Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough. J Mol Biol 348: 801-815.
27. Kramer EB, Vallabhaneni H, Mayer LM, Farabaugh PJ, (2010) A comprehensive analysis of translational missense errors in the yeast Saccharomyces cerevisiae. RNA 16: 1797-1808.
28. Lynch SR, Puglisi JD, (2001) Structural origins of aminoglycoside specificity for prokaryotic ribosomes. J Mol Biol 306: 1037-1058.
29. Schroeder SJ, Blaha G, Moore PB, (2007) Negamycin binds to the wall of the nascent chain exit tunnel of the 50S ribosomal subunit. Antimicrob Agents Chemother 51: 4462-4465.
30. Yang LY, Trujillo JM, (1990) Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods. Cancer Res 50: 3218-3225.
31. Dexter DL, Spremulli EN, Fligiel Z, Barbosa JA, Vogel R, et al. (1981) Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med 71: 949-956.
32. Bidou L, Stahl G, Hatin I, Namy O, Rousset JP, et al. (2000) Nonsense-mediated decay mutants do not affect programmed-1 frameshifting. RNA 6: 952-961.
33. Oh JH, Ku JL, Yoon KA, Kwon HJ, Kim WH, et al. (1999) Establishment and characterization of 12 human colorectal-carcinoma cell lines. Int J Cancer 81: 902-910.